Thermo Fisher Scientific (TMO) Non-Current Debt (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Non-Current Debt for 18 consecutive years, with $40.1 billion the latest figure, recorded in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $40.1 billion, up 27.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.1 billion (up 27.74% YoY), and the FY2025 annual result was $35.9 billion, up 23.37% from the prior year.
• Non-Current Debt was $40.1 billion for Q1 2026 at Thermo Fisher Scientific, up from $35.9 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $40.1 billion in Q1 2026 and troughed at $28.2 billion in Q4 2022.
• Average Non-Current Debt over 5 years is $31.3 billion, with a median of $31.2 billion recorded in 2024.
• The widest YoY moves for Non-Current Debt: up 68.39% in 2022, down 10.59% in 2022.
• Over 5 years, Non-Current Debt stood at $28.9 billion in 2022, then advanced by 8.3% to $31.3 billion in 2023, then retreated by 7.18% to $29.1 billion in 2024, then climbed by 23.37% to $35.9 billion in 2025, then climbed by 11.77% to $40.1 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $40.1 billion in Q1 2026, $35.9 billion in Q4 2025, and $31.9 billion in Q3 2025.